無意中看到一篇關(guān)于IC/BPS的非腫瘤文章，還有臨床驗證，非常值得模仿。
Title: Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome
PMID：36069808
-
所用數(shù)據(jù)集：GSE11783，GSE57560，GSE621
背景知識：肥大細(xì)胞異?；罨挖吇荌C/BPS的主要病理機(jī)制之一。（HMC-1肥大細(xì)胞)
同類型疾?。篻landular cystitis/Cystitis glandularis腺性膀胱炎
-
文章思路：
-
加分項1
感覺文章中加分項是臨床驗證部分，作者選取了10對IC/BPS病人標(biāo)本+10對正常膀胱組織（來自膀胱癌病人）。
Fig.4 -
加分項2
作用最后在HMC-1肥大細(xì)胞中敲低目標(biāo)基因BTK，進(jìn)行CCK-8、遷移和肥大細(xì)胞脫粒指標(biāo)檢測。
Fig.5
- 彩蛋→Q:那么我們應(yīng)該如何研究IC/BPS呢？
當(dāng)然可以建立動物模型的，類型這篇文章The NLRP3 Inflammasome Inhibitor Dapansutrile Attenuates Cyclophosphamide-Induced Interstitial Cystitis.(PMID：35720309)
參考鏈接:
- Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome(PMID:36069808)
- WGCNA and molecular docking reveal key hub genes and potential natural inhibitor in interstitial cystitis/bladder pain syndrome(PMID：35333927)
- Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion(PMID：32575815)
